1 WM, a form of LPL tumor distinguished by IgM paraproteinemia.

2 CRBV expression in patients with myeloma and paraproteinemia.

3 ly seen in the kidney and is associated with paraproteinemia.

4 t(9;14)(p13;q32) in 50% of patients who lack paraproteinemia.

5  patients who have peripheral neuropathy and paraproteinemia among other multisystem manifestations.

6 tained the clinical course of maculopathy in paraproteinemia and investigated the effect of various t

7 t to LPL tumors that are not associated with paraproteinemia and that have frequent t(9;14)(p13;q32)

8                                Patients with paraproteinemia have abnormalities in their T-cell subse

9                 All patients had evidence of paraproteinemia in a setting of monoclonal gammopathy of

10 dosis associated with immunoglobulin M (IgM) paraproteinemia is rare.

11 ia (WM), which has an immunoglobulin M (IgM) paraproteinemia, is classified as an LPL.

12 ght chains monomeric bands were found in non-paraproteinemia related kidney disease controls.

13 opathy of undetermined significance, and non-paraproteinemia related kidney disease controls.

14                                              Paraproteinemia relates to monoclonal gammopathy-produci

15                      AL amyloidosis with IgM paraproteinemia represents a distinctive subset of patie

16             In order to treat the underlying paraproteinemia, the patient was started on bortezomib a

17 f monoclonal components (in order to exclude paraproteinemias), were tested for total IgE (that were

18                 The records of patients with paraproteinemia with optical coherence tomography (OCT)